SCHEMBL21032129

SCHEMBL21032129

COC(=O)c1cc(Cl)cc(C(C)C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
MAPT P10636 3/20 0.47
MEN1 O00255 1/20 0.47
HPGD P15428 1/20 0.47
XBP1 P17861 1/20 0.47
HTT P42858 1/20 0.47
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CA12 O43570 2/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA7 P43166 2/20 0.46
CA9 Q16790 2/20 0.46
CA14 Q9ULX7 2/20 0.46
L3MBTL1 Q9Y468 3/20 0.44
KDM4E B2RXH2 2/20 0.44
LMNA P02545 2/20 0.44
XDH P47989 2/20 0.44
POLB P06746 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22081904 0.88 ALDH1A1 (0.46) ALDH1A1MAPTMEN1HPGDXBP1
SCHEMBL14200326 0.87 CA1 (0.54) ALDH1A1MAPTHPGDCA12CA1
SCHEMBL14682706 0.87 CA1 (0.54) ALDH1A1MAPTMEN1HPGDXBP1
SCHEMBL22081873 0.86 MAPT (0.45) ALDH1A1MAPTMEN1HPGDXBP1
SCHEMBL16961232 0.86 ALDH1A1 (0.45) ALDH1A1MAPTMEN1HPGDXBP1
SCHEMBL23411505 0.84 ALDH1A1 (0.46) ALDH1A1MAPTMEN1HPGDXBP1
SCHEMBL23411862 0.84 MAPT (0.46) ALDH1A1MAPTMEN1HPGDXBP1
SCHEMBL29903422 0.84 MAPT (0.46) ALDH1A1MAPTMEN1HPGDXBP1
SCHEMBL67540 0.82 ALDH1A1 (0.62) ALDH1A1MAPTMEN1HPGDXBP1
SCHEMBL588343 0.82 ALDH1A1 (0.62) ALDH1A1MAPTMEN1HPGDXBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190275012-A9 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS LUPIN LIMITED (IN) 2019-09-12 US disclosed
US-20190160045-A1 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS LUPIN LTD (IN) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190275012-A9 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS MALT1, PTP4A1, PTPRO ALDH1A1 1217/4885MAPT 2864/4885MEN1 478/4885
US-20190160045-A1 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS MALT1, PTP4A1, PTPRO ALDH1A1 1217/4885MAPT 2864/4885MEN1 478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.